- Corporate Officers - B
- Beshar Luke M
Insider Trading History of Beshar Luke M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Beshar Luke M since 2006.
This trader's CIK number is 1192128.
At the time of last reporting, Beshar Luke M was the Officer of Protara Therapeutics, Inc.. (stock ticker symbol TARA).
Also see all insider trading activities at Protara Therapeutics, Inc..
Note that in the past
BESHAR LUKE M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Protara Therapeutics, Inc. (TARA) by Beshar Luke M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TARA | 30,000 | $118,060 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nps Pharmaceuticals Inc (NPSP) by Beshar Luke M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | NPSP | 0 | $0 | 0 | $0 | 21,785 | $135,399 |
| 2014 | NPSP | 0 | $0 | 171,923 | $5,468,172 | 195,631 | $973,089 |
| 2013 | NPSP | 0 | $0 | 298,185 | $6,818,796 | 318,185 | $1,564,237 |
| 2011 | NPSP | 20,000 | $107,200 | 50,000 | $500,000 | 50,000 | $202,500 |
Yearly summary of insider trading at Regenxbio Inc. (RGNX) by Beshar Luke M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | RGNX | 0 | $0 | 33,291 | $2,164,478 | 33,291 | $534,438 |
Yearly summary of insider trading at Cambrex Corp (CBM) by Beshar Luke M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | CBM | 0 | $0 | 57,359 | $710,504 | 14,875 | $109,925 |
| 2006 | CBM | 0 | $0 | 95,800 | $2,155,236 | 96,500 | $1,937,636 |
Insider trading activities at 4 companies by Beshar Luke M:
1. Protara Therapeutics, Inc. (TARA)
2. Nps Pharmaceuticals Inc (NPSP)
3. Regenxbio Inc. (RGNX)
4. Cambrex Corp (CBM)
Table 1. Insider trading of Protara Therapeutics, Inc. (TARA) by Beshar Luke M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-30 | TARA | Buy | 10,000 | 3.10 | 31,000 |
| 2022-03-14 | TARA | Buy | 10,000 | 4.25 | 42,500 |
| 2022-03-10 | TARA | Buy | 10,000 | 4.46 | 44,560 |
Table 2. Insider trading of Nps Pharmaceuticals Inc (NPSP) by Beshar Luke M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-17 | NPSP | Option Ex | 7,422 | 18.24 | 135,399 |
| 2015-02-12 | NPSP | Option Ex | 3,832 | .00 | 0 |
| 2015-02-13 | NPSP | Option Ex | 10,531 | .00 | 0 |
| 2014-12-17 | NPSP | Option Ex | 52,258 | 6.59 | 344,536 |
| 2014-12-17 | NPSP | Sale | 52,258 | 35.00 | 1,829,030 |
| 2014-11-17 | NPSP | Option Ex | 47,442 | 5.81 | 275,780 |
| 2014-11-17 | NPSP | Sale | 47,442 | 30.01 | 1,423,639 |
| 2014-10-31 | NPSP | Sale | 10,000 | 29.00 | 290,000 |
| 2014-10-27 | NPSP | Sale | 30,635 | 26.75 | 819,608 |
| 2014-08-13 | NPSP | Option Ex | 53,813 | 4.59 | 247,270 |
| 2014-02-13 | NPSP | Option Ex | 10,530 | .00 | 0 |
| 2014-01-08 | NPSP | Sale | 31,588 | 35.01 | 1,105,895 |
| 2014-01-08 | NPSP | Option Ex | 31,588 | 3.34 | 105,503 |
| 2013-12-26 | NPSP | Option Ex | 37,874 | 4.53 | 171,379 |
| 2013-12-26 | NPSP | Sale | 37,874 | 30.02 | 1,136,977 |
| 2013-12-12 | NPSP | Option Ex | 60,311 | 8.23 | 496,359 |
| 2013-12-12 | NPSP | Sale | 60,311 | 24.02 | 1,448,368 |
| 2013-09-20 | NPSP | Option Ex | 50,000 | 5.78 | 289,000 |
| 2013-09-20 | NPSP | Sale | 50,000 | 30.24 | 1,511,850 |
| 2013-09-16 | NPSP | Option Ex | 50,000 | 4.05 | 202,500 |
| 2013-09-16 | NPSP | Sale | 50,000 | 28.27 | 1,413,500 |
| 2013-05-09 | NPSP | Option Ex | 45,150 | 4.05 | 182,857 |
| 2013-05-09 | NPSP | Sale | 45,150 | 14.18 | 640,001 |
| 2013-04-29 | NPSP | Option Ex | 4,850 | 4.05 | 19,642 |
| 2013-04-29 | NPSP | Sale | 4,850 | 14.00 | 67,900 |
| 2013-04-10 | NPSP | Sale | 50,000 | 12.00 | 600,200 |
| 2013-04-10 | NPSP | Option Ex | 50,000 | 4.05 | 202,500 |
| 2013-02-19 | NPSP | Option Ex | 20,000 | .00 | 0 |
| 2011-11-09 | NPSP | Buy | 20,000 | 5.36 | 107,200 |
| 2011-01-31 | NPSP | Sale | 50,000 | 10.00 | 500,000 |
| 2011-01-31 | NPSP | Option Ex | 50,000 | 4.05 | 202,500 |
Table 3. Insider trading of Regenxbio Inc. (RGNX) by Beshar Luke M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-11-29 | RGNX | Option Ex | 12,784 | 3.76 | 48,067 |
| 2018-11-29 | RGNX | Sale | 12,784 | 65.00 | 830,960 |
| 2018-11-27 | RGNX | Sale | 18,786 | 65.03 | 1,221,653 |
| 2018-11-26 | RGNX | Sale | 1,721 | 65.00 | 111,865 |
| 2018-11-27 | RGNX | Option Ex | 18,786 | 21.36 | 401,268 |
| 2018-11-26 | RGNX | Option Ex | 1,721 | 49.45 | 85,103 |
Table 4. Insider trading of Cambrex Corp (CBM) by Beshar Luke M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-10-10 | CBM | Sale | 23,192 | 11.01 | 255,320 |
| 2007-10-02 | CBM | Sale | 12,500 | 11.00 | 137,500 |
| 2007-10-02 | CBM | Option Ex | 6,375 | 7.39 | 47,111 |
| 2007-10-02 | CBM | Sale | 12,500 | 11.00 | 137,500 |
| 2007-10-02 | CBM | Option Ex | 6,375 | 7.39 | 47,111 |
| 2007-08-20 | CBM | Option Ex | 2,125 | 7.39 | 15,703 |
| 2007-08-20 | CBM | Sale | 2,125 | 13.25 | 28,156 |
| 2007-01-29 | CBM | Sale | 3,521 | 21.59 | 76,014 |
| 2007-01-29 | CBM | Sale | 3,521 | 21.59 | 76,014 |
| 2006-11-20 | CBM | Sale | 35,844 | 22.41 | 803,084 |
| 2006-11-20 | CBM | Option Ex | 36,544 | 19.05 | 696,163 |
| 2006-11-16 | CBM | Sale | 30,700 | 22.65 | 695,355 |
| 2006-11-17 | CBM | Sale | 29,256 | 22.45 | 656,797 |
| 2006-11-16 | CBM | Option Ex | 30,700 | 21.31 | 654,247 |
| 2006-11-17 | CBM | Option Ex | 29,256 | 20.07 | 587,226 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Beshar Luke M
(Officer of Protara Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.